Pharmaceutical Risk Management Tools: Getting the Most Out of ICH Q9
This course is not currently scheduled. Click on the Notify Me button to the left to be notified when it is scheduled.
This course is available as a client site course. Please click here for more information.
Who Should Attend
This comprehensive quality system workshop will benefit professionals who are involved in managing and operating in the ICH Q8, Q9 and Q10 areas, as well as those who interact with PAT and QbD programs, including:
• PAT and QbD Team Leaders and Members
• Quality and Efficiency Personnel
• Manufacturing Operations Personnel
• Product Development Teams
• Technology Transfer Personnel
• In-process and Finished Goods Analysts
• Analytical Instrument and Manufacturing Equipment
Suppliers
• Managers tasked with improving pharmaceutical operating
efficiency
Description
ICH Q9 is one of the three “cornerstone” guidances proposed by the International Conference on Harmonization and undergoing adoption in The European Union, Japan and the USA. These policies, called Q8, Q9 and Q10, form an international platform that will dramatically improve efficiency and safety within the entire pharmaceutical life cycle. ICH Q8 and Q10 cover drug manufacturing and drug development by treating their individual operating steps as entities that are subject to variance. The platforms aim to reduce stepwise variance so that the likelihood of failure or rejection at the conclusion of the process is minimal. Both use risk-management techniques to accomplish their goals.
Risk management involves assessment of pharmaceutical unit operations for critical-to-quality attributes, evaluation of tolerable variance, measurement and control of those parameters and eventually, high release rates with minimal likelihood of recall or patient risk. Putting risk management into practice involves multivariate analysis of all development and production factors.
This course provides both principles and practices for successful ICH Q9 implementation.